Cross reactivity between many anti-human antibodies for their hamster homologs provide the tools to study the signal transduction pathway activated by asbestos and SV40 in the malignant mesothelioma model

Barbara Kroczynska*, Michele Carbone

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

The aim of this study was to test the possibility of using human antibodies to study the pathogenic mechanism of SV40 and asbestos in a hamster mesothelioma model. The cellular lysates from human and hamster primary mesothelial cells were tested by Western blot analysis. All of the antibodies we tested (HGF, Notch, VEGF, Sp1, p53, PP2A, p-ERK1, p-c-jun, Fra1, Fra2, MMP1, MMP9, NFκB p65, IκB, GAPDH) cross-reacted with their hamster counterparts. These data indicate that hamster mesothelioma model and more in general hamster experimental model, can be used for functional studies because many mouse, rabbit, and goat monoclonal antibodies prepared against human antigens cross-react with their hamster counterparts.

Original languageEnglish (US)
Pages (from-to)537-542
Number of pages6
JournalMolecular Carcinogenesis
Volume45
Issue number7
DOIs
StatePublished - Jul 2006

Keywords

  • Asbestos
  • Mesothelial cells
  • Mesothelioma
  • SV40

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Fingerprint Dive into the research topics of 'Cross reactivity between many anti-human antibodies for their hamster homologs provide the tools to study the signal transduction pathway activated by asbestos and SV40 in the malignant mesothelioma model'. Together they form a unique fingerprint.

  • Cite this